Extra Gene Findings May Change Care In TSC

What was studied

Researchers looked for extra genetic changes, beyond the usual TSC1 and TSC2 changes, in people who already had tuberous sclerosis complex (TSC). They studied 224 individuals with TSC.

They used exome sequencing and SNP array testing to search for pathogenic gene changes and copy number variants associated with epilepsy or neurodevelopmental disorders. The team interpreted results using ACMG guidelines and confirmed important findings with additional testing.

What they found

Among 224 people with TSC, 8 had at least 1 additional pathogenic genetic finding associated with increased risk for epilepsy, intellectual disability, or other neurodevelopmental disorders. This was 3.6% of the group. The researchers found 6 pathogenic variants in epilepsy-associated genes and 3 pathogenic copy number variants associated with neurodevelopmental disorders.

The authors said these extra findings had clinical implications for medical follow-up, expected outlook, and family recurrence risk. They also reported that 44% had direct targeted therapy relevance, such as gene therapy or certain antiseizure medicines.

Limits of the evidence

This study reports how often extra pathogenic findings were found in this group, but it does not prove that every extra variant explained a person's symptoms or changed outcomes. The abstract does not describe the ages, seizure types, developmental features, or how representative this TSC group was, so it is hard to know how well the results apply to all people with TSC.

The number of people with extra findings was small, and the abstract does not list the specific genes or copy number changes. It also does not show whether broader testing improved health over time.

For families and caregivers

For families, this suggests that a small number of people with TSC may also have another genetic condition associated with epilepsy or developmental challenges. Knowing about an extra genetic diagnosis could help inform monitoring, prognosis, treatment considerations, and information about future pregnancies.

At the same time, most people in this study did not have an additional pathogenic finding, and this study alone does not show that everyone with TSC should have the same expanded testing. Families can ask whether broader genetic testing has been considered and how results might or might not change care.

What to watch next

Stronger evidence would come from larger studies that show which extra genes are found most often in TSC and whether finding them changes treatment decisions or long-term outcomes.

Terms in this summary

tuberous sclerosis complex (TSC)

A genetic condition that can affect the brain and other organs and often raises the risk of seizures and developmental problems.

exome sequencing

A genetic test that reads the parts of genes that contain instructions for making proteins.

SNP array

A test that looks for missing or extra pieces of DNA across the genome.

pathogenic variant

A DNA change classified as disease-causing.

copy number variant

A section of DNA that is deleted or duplicated, which can affect health.

neurodevelopmental disorders

Conditions that affect brain development, learning, behavior, or thinking.

ACMG guidelines

Standard rules used by genetics experts to decide how important a DNA change is.